Biometrics

Statistical Consulting

Optimize your clinical development—from study design to submission and beyond—with our innovative statistical strategies

Reduce costs and timeline of your clinical trial

Our dedicated, in-house experts use the most innovative methods to support the development of study designs across a wide range of therapeutic areas and phases for both medical devices and drugs.

We’ll work closely with you to support regulatory interactions and oversight implementation.

No matter how complex your project, get tailored, comprehensive support, including:
  • Statistical strategy for clinical development plans
  • Study design and protocol development
  • Power and Sample size calculation
  • Implementation of complex statistical methodologies
  • Support for interim analyses
  • Support for Data Monitoring Committees / Data Safety Monitoring Boards
  • Support for regulatory interactions

Why choose Alira Health?

Alira Health biometrics team has provided expert statistical guidance for over 500 projects. As our partner, you’ll benefit from:

  • Working with the subject matter experts and statistical consultants with over 20 years of clinical development experience
  • Strategic input on clinical development plans and protocols
  • Strong know-how in the latest statistical methods
  • Direct access to an in-house team of regulatory experts

Related News

Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Multimedia April 15, 2022
Alira Health’s Transformation Talks: Real-World Evidence Strategy Playbook
As a special guest, our episode “Real-World Evidence Strategy Playbook” with Romain Finas, Vice President of Real-World Evidence at Alira Health, is now live! Listen to this podcast(...)
Clinical RWE
Multimedia April 13, 2022
Fireside Chat Replay: Clinical Trials in Rare Disease: Best Practices for Integrating the Patient Voice
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical Patient Engagement
Events April 12, 2022
SCOPE Europe 2022
We are thrilled to announce that this year we will be joining the 4th Annual Summit for Clinical Trials Operations Executives Europe (SCOPE Europe).
Clinical
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.